ATHE logo

ATHE

Profile

Full Name

Alterity Therapeutics Limited

Ticker Symbol

ATHE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Australia

IPO

September 29, 2003

Indexes

Not included

Website

http://alteritytherapeutics.com

Employees

10

Key Details

Price

$3.30(+2.80%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.05(+11.11% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.30
ATHE price is $3.30

30-Day Relative Volume

0.32
ATHE 30-day relative volume is 0.32

Price Performance

Price Today change

+2.8%
ATHE price is up +2.8% today

Price YTD change

-0.3%
ATHE price is down -0.3% since January 1st

Price 1-year change

+34.69%
ATHE price is up +34.69% year-on-year

Price 3-year change

-57.69%
ATHE price is down -57.69% over the past 3 years

Price Range

Price All-time high

$797.40
ATHE price is currently -99.59% below its historical high of $797.40

Price 3-year low

$1.00
ATHE price is currently +230.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$48.85M
ATHE market capitalization is $48.85 million

Market cap 3-year change

+56.13%
ATHE market capitalization is up +56.13% over the past 3 years

Market cap All-time high

$513.50M
ATHE market capitalization is currently -90.49% below its historical high of $513.50 million

Market cap sector rank

37.75%
ATHE market capitalization is higher than 37.75% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+69.57%
ATHE shares outstanding is up +69.57% year-on-year

Shares Outstanding 3-Year Change

+269.02%
ATHE shares outstanding is up +269.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.14
ATHE beta is 1.14

200-day SMA

$2.30
ATHE price is currently +43.42% above its 200-day simple moving average

50-day SMA

$3.72
ATHE price is currently -11.36% below its 50-day simple moving average

RSI

49.36
ATHE 14-day relative strength index is 49.36

Volume

0.32
ATHE 30-day relative volume is 0.32

ATR

$0.26
ATHE average true range is $0.26

10-day Historical Volatility

94.21%
ATHE 10-day historical volatility is 94.21%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ATHE annual revenue value is unknown

Revenue Analysts estimate

$3.00M
ATHE annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
ATHE annual revenue 1-year change is unknown

Revenue Sector rank

-
ATHE annual revenue is unknown

EPS

EPS

-$2.05
ATHE annual earnings per share is -$2.05

EPS Analysts estimate

-$0.82
ATHE annual earnings per share is currently +149.44% higher than the consensus analysts' forecast

EPS 1-year change

+11.11%
ATHE annual earnings per share is up +11.11% year-on-year

EPS Sector rank

38.13%
ATHE annual earnings per share is higher than 38.13% of companies in Healthcare sector

Profit

Gross profit

-
ATHE annual gross profit value is unknown

Gross margin

-
ATHE annual gross profit margin value is unknown

Operating profit

-$12.71M
ATHE annual operating income is -$12.71 million

Operating margin

-
ATHE annual operating profit margin value is unknown

Net income

-$12.54M
ATHE annual net profit is -$12.54 million

Net margin

-
ATHE annual net profit margin value is unknown

Expenses

Total expenses

$12.71M
ATHE annual total expenses is $12.71 million

Operating expenses

$12.71M
ATHE annual total operating expenses is $12.71 million

Cost of goods sold

-
ATHE annual cost of goods sold value is unknown

Selling, general & administrative expenses

$3.03M
ATHE annual SGA is $3.03 million

Depreciation and amortization

$96.70K
ATHE annual depreciation & amortization is $96.70 thousand

Interest expense

-
ATHE annual interest expense value is unknown

Income tax

$30.20K
ATHE annual income tax is $30.20 thousand

EBIT & EBITDA

EBIT

-$12.71M
ATHE annual earnings before interest & taxes is -$12.71 million

EBITDA

-$12.62M
ATHE annual EBITDA is -$12.62 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.85M
ATHE annual total assets is $12.85 million

Non current assets

$124.90K
ATHE annual long term assets is $124.90 thousand

Current assets

$12.72M
ATHE annual total current assets is $12.72 million

Cash and cash equivalents

$8.45M
ATHE annual cash & cash equivalents is $8.45 million

Accounts receivable

$0.00
ATHE annual accounts receivable is $0.00

Inventory

-
ATHE annual inventory value is unknown

Liabilities

Total liabilities

$3.63M
ATHE annual total liabilities is $3.63 million

Long term liabilities

$34.70K
ATHE annual total long term liabilities is $34.70 thousand

Current liabilities

$3.59M
ATHE annual total current liabilities is $3.59 million

Accounts payable

$388.40K
ATHE annual accounts payable is $388.40 thousand

Debt

Total debt

$106.30K
ATHE annual total debt is $106.30 thousand

Total debt 1-year change

-23.64%
ATHE annual total debt is down -23.64% year-on-year

Long term debt

$34.70K
ATHE annual long term debt is $34.70 thousand

Short term debt

$71.60K
ATHE annual short term debt is $71.60 thousand

Equity & Capital

Shareholders equity

$9.22M
ATHE annual stockholders equity is $9.22 million

Book value

$9.22M
ATHE annual book value is $9.22 million

Retained earnings

-$143.15M
ATHE annual retained earnings is -$143.15 million

Working capital

$9.13M
ATHE annual working capital is $9.13 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.26M
ATHE annual cash flow from operations is -$8.26 million

Cash from operations 1-year change

+38.7%
ATHE annual cash flow from operations is up +38.7% year-on-year

Cash from investing

-$3800.00
ATHE annual cash flow from investing activities is -$3800.00

Cash from investing 1-year change

+84.49%
ATHE annual cash flow from investing activities is up +84.49% year-on-year

Cash from financing

$6.04M
ATHE annual cash flow from financing activities is $6.04 million

Cash from financing 1-year change

+7118.64%
ATHE annual cash flow from financing activities is up +7118.64% year-on-year

CAPEX

CAPEX

-
ATHE annual capital expenditures value is unknown

CAPEX 1-year change

-
ATHE annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$8.27M
ATHE annual free cash flow is -$8.27 million

Free cash flow 1-year change

+38.69%
ATHE annual free cash flow is up +38.69% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ATHE annual gross profit margin value is unknown

Operating margin

-
ATHE annual operating profit margin value is unknown

Net margin

-
ATHE annual net profit margin value is unknown

ROA & ROE

ROA

-97.57%
ATHE annual return on assets is -97.57%

ROE

-135.94%
ATHE annual return on equity is -135.94%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ATHE price to earnings ratio value is unknown

PE ratio Sector rank

-
ATHE price to earnings ratio is unknown

PB Ratio

PB ratio

10.09
ATHE price to book ratio is 10.09

PB ratio Sector rank

92.51%
ATHE price to book ratio is higher than 92.51% of companies in Healthcare sector

PS Ratio

PS ratio

-
ATHE price to sales ratio value is unknown

PS ratio Sector rank

-
ATHE price to sales ratio is unknown

Enterprise value

Enterprise value

$46.10M
ATHE enterprise value is $46.10 million

Enterprise value Sector rank

40.17%
ATHE enterprise value is higher than 40.17% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
ATHE EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
ATHE EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.54
ATHE annual current ratio is 3.54

Quick ratio

-
ATHE annual quick ratio value is unknown

Leverage

Debt to equity

0.01
ATHE annual debt to equity ratio is 0.01

Interest coverage ratio

-
ATHE annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ATHE piotroski f-score value is unknown

Altman Z-Score

-
ATHE altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Jan 30, 25 Maxim Group
Buy
Dec 12, 24 Maxim Group
Buy
Mar 7, 24 Benchmark
Speculative Buy
Jun 5, 23 Ladenburg Thalmann
Buy
Aug 3, 22 Ladenburg Thalmann
Buy
Jun 23, 22 Goldman Sachs
Neutral
Aug 20, 21 Benchmark
Speculative Buy

Institutional Ownership

Similar stocks

Citius Oncology (CTOR)
ZOM logo
Zomedica (ZOM)
Artiva Biotherapeutics (ARTV)
BYSI logo
BeyondSpring (BYSI)
Acrivon Therapeutics (ACRV)
ACET logo
Adicet Bio (ACET)
DTIL logo
Precision BioSciences (DTIL)
MAIA logo
MAIA Biotechnology (MAIA)
IMRX logo
Immuneering (IMRX)
  • What is the ticker symbol for Alterity Therapeutics Limited?
  • Does Alterity Therapeutics Limited pay dividends?
  • What sector is Alterity Therapeutics Limited in?
  • What industry is Alterity Therapeutics Limited in?
  • What country is Alterity Therapeutics Limited based in?
  • When did Alterity Therapeutics Limited go public?
  • Is Alterity Therapeutics Limited in the S&P 500?
  • Is Alterity Therapeutics Limited in the NASDAQ 100?
  • Is Alterity Therapeutics Limited in the Dow Jones?
  • When was Alterity Therapeutics Limited's last earnings report?
  • When does Alterity Therapeutics Limited report earnings?

What is the ticker symbol for Alterity Therapeutics Limited?

The ticker symbol for Alterity Therapeutics Limited is NASDAQ:ATHE

Does Alterity Therapeutics Limited pay dividends?

No, Alterity Therapeutics Limited does not pay dividends

What sector is Alterity Therapeutics Limited in?

Alterity Therapeutics Limited is in the Healthcare sector

What industry is Alterity Therapeutics Limited in?

Alterity Therapeutics Limited is in the Biotechnology industry

What country is Alterity Therapeutics Limited based in?

Alterity Therapeutics Limited is headquartered in Australia

When did Alterity Therapeutics Limited go public?

Alterity Therapeutics Limited's initial public offering (IPO) was on September 29, 2003

Is Alterity Therapeutics Limited in the S&P 500?

No, Alterity Therapeutics Limited is not included in the S&P 500 index

Is Alterity Therapeutics Limited in the NASDAQ 100?

No, Alterity Therapeutics Limited is not included in the NASDAQ 100 index

Is Alterity Therapeutics Limited in the Dow Jones?

No, Alterity Therapeutics Limited is not included in the Dow Jones index

When was Alterity Therapeutics Limited's last earnings report?

Alterity Therapeutics Limited's most recent earnings report was on Feb 28, 2025

When does Alterity Therapeutics Limited report earnings?

The next expected earnings date for Alterity Therapeutics Limited is May 15, 2025
On this page